Neogen Chemicals Limited — Results, 01-02-2025: Integrated Filing- Financial

Neogen Chemicals Ltd. held a board meeting approving the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. Standalone revenue from operations reached ₹200.41 crore, a year-on-year increase from ₹164.47 crore, resulting in a profit of ₹14.41 crore. The board also addressed the merger with its wholly-owned subsidiary, Buli Chemicals India, effective April 1, 2024, restating prior financial figures accordingly. This update positions Neogen to enhance operational efficiency and focus on growth, which could foster a positive outlook among investors.